BOULDER, Colo., May 7, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas and the UBS Global Healthcare Conference in New York City. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: investor.arraybiopharma.com.

http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO



    Event:     Bank of America Merrill Lynch
               Healthcare Conference

    Date:     Thursday, May 14, 2015

    Time:     12:00 p.m. PDT

    Location:  Encore at the Wynn, Las Vegas,
               NV




    Event:     UBS Global Healthcare
               Conference

    Date:     Tuesday, May 19, 2015

    Time:      8:30 a.m. EDT

    Location:  Sheraton New York Times Square
               Hotel, NYC, NY

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.



    CONTACT:                        Tricia Haugeto

                                    Array BioPharma Inc.

                                    303-386-1193

                                    thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-bank-of-america-merrill-lynch-healthcare-conference-and-the-ubs-global-healthcare-conference-300078488.html

SOURCE Array BioPharma Inc.